Erie Indemnity Cl A saw its IBD SmartSelect Composite Rating rise to 97 Friday, up from 94 the day before.
The new rating shows the stock is outpacing 97% of all stocks when it comes to the most important stock-picking criteria.
Erie Indemnity Cl A broke out earlier, but has fallen back below the prior 411.72 entry from a double bottom. If a stock you're tracking clears a buy point then declines 7% or more below the original entry price, it's considered a failed base. It's best to wait for the stock to form a new pattern and breakout.
Discover The 3 Keys To Successful Stock Investing
The stock has a 94 EPS Rating, meaning its recent quarterly and annual earnings growth tops 94% of all stocks.
Its Accumulation/Distribution Rating of B shows moderate buying by institutional investors over the last 13 weeks.
The company reported 37% earnings-per-share growth for Q4. Top line growth came in at 13%, down from 16% in the prior quarter. The company's next quarterly report is expected on or around Apr. 24.
Erie Indemnity Cl A holds the No. 5 rank among its peers in the Insurance-Brokers industry group. Baldwin Insurance Cl A is the No. 1-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
